Plant Summary
Plant Information
TCMBank_ID: | TCMBANKHE008069 |
YEM_ID: | YEM-344 |
ID: | TCMBANKHE008069/YEM-344 |
植物拉丁名: |
|
功能与主治: | To strengthen heart, disinhibit urine and disperse edema./Cardiac failure, paroxysmal supraventricular tachycardia, paroxysmal fibrillation. |
药用植物名: | 黄花夹竹桃 |
药名: | 黄花夹竹桃 |
来源: | 云南民族药物志：第二卷 |
药用部位: | seed |
使用民族: | 傣族/佤族 |
TCM_ID_id: | 7577 |
植物对应的化合物
| 化合物ID | 化合物名 | 别名 | 分子式 | 分子质量 | Smiles |
|---|
| TCMBANKIN000768 | peruvoside-2'-monoacetate | C32H46O10 | CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CCC5C6=CC(=O)OC6)O)C)C=O)OC(=O)C)OC)O | ||
| TCMBANKIN001224 | lupinine | C10H19NO | 169.26 g/mol | C1CCN2CCCC(C2C1)CO | |
| TCMBANKIN001614 | sabialactone | C30H46O4 | CC1(CCC23CCC4(C5(CCC6C(C(=O)CCC6(C5CC(C4(C2C1)O)OC3=O)C)(C)C)C)C)C | ||
| TCMBANKIN003447 | cerberoside | C42H66O18 | 859 g/mol | CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CCC5C6=CC(=O)OC6)O)C)C)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)O)O)OC)O | |
| TCMBANKIN008481 | Ruvoside | 3-[(5R,10R,14S)-3-[(2R,3S,4R,5S,6S)-3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl]oxy-14-hydroxy-10-(hydroxymethyl)-13-methyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one; ruvoside; AC1O3DXD | C30H46O9 | 550.68 | [HH].CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CCC5C6=CC(=O)OC6)O)C)CO)O)OC)O |
| TCMBANKIN010356 | quercetin-3-o-[(6-o-sinapoyl)-β-d-glucopyra-nosyl-(1→2)-β-d-galactopyranoside] | C38H40O21 | COC1=CC(=CC(=C1O)OC)C=CC(=O)OCC2C(C(C(C(O2)OC3C(C(C(OC3OC4=C(OC5=CC(=CC(=C5C4=O)O)O)C6=CC(=C(C=C6)O)O)CO)O)O)O)O)O | ||
| TCMBANKIN010481 | theviridoside | C17H24O11 | 404.4 g/mol | COC(=O)C1=COC(C2C1(CC=C2CO)O)OC3C(C(C(C(O3)CO)O)O)O | |
| TCMBANKIN010896 | petasin | C20H28O3 | 316.4 g/mol | CC=C(C)C(=O)OC1CCC2=CC(=O)C(CC2(C1C)C)C(=C)C | |
| TCMBANKIN012967 | petasitenine | C19H27NO7 | 381.4 g/mol | CC1CC2(C(O2)C)C(=O)OC3CCN(CC=C(C3=O)COC(=O)C1(C)O)C | |
| TCMBANKIN017905 | petasalbin | C15H22O2 | 234.33 g/mol | CC1CCCC2C1(C(C3=C(C2)OC=C3C)O)C | |
| TCMBANKIN018998 | kaempferol 3-o-[(6-o-feruloyl)-β-d-glucopy-ranosyl-(1→2)-β-d-galactopyranoside] | C37H38O19 | |||
| TCMBANKIN020905 | thevetin b | C42H66O18 | 859 g/mol | CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CCC5C6=CC(=O)OC6)O)C)C)O)OC)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)O)O | |
| TCMBANKIN022142 | kaempferol-3-o-[(6-o-sinapoyl)-β-d-glucopyra-nosyl-(1→2)-β-d-galactopyranoside] | C38H40O20 | |||
| TCMBANKIN022372 | nerinine | C19H25NO5 | 347.4 g/mol | CN1CCC2=CCC3C(C21)C4=CC(=C(C(=C4C(O3)O)OC)OC)OC | |
| TCMBANKIN022821 | vertia flavone | C16H12O5 | COC1=C2C(=CC(=C1)O)OC(=CC2=O)C3=CC=C(C=C3)O | ||
| TCMBANKIN023957 | malayoside | C29H42O9 | 534.6 g/mol | CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CCC5C6=CC(=O)OC6)O)C)C=O)O)O)O | |
| TCMBANKIN025320 | verticillatine | C20H25ClN2O3 | 0 | CC1C2COC(C3C2CC4[N+]1(C3CC5=C4NC6=C5C=C(C=C6)O)C)O.[Cl-] | |
| TCMBANKIN025687 | Thiamine | (Riboflavin); thiamine; thiamine chloride; vitamin b1 | C12H18Cl2N4OS | 337.3 g/mol | [H+].CC1=C(SC=[N+]1CC2=CN=C(N=C2N)C)CCO.[Cl-].[Cl-] |
| TCMBANKIN025931 | peruvoside | C30H44O9 | 548.66 | CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CCC5C6=CC(=O)OC6)O)C)C=O)O)OC)O | |
| TCMBANKIN027838 | Lupeol acetate | lupeol acetate; 3-Acetyllupeol; Acetic acid (1R,3aR,4S,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-1-isopropenyl-3a,5a,5b,8,8,11a-hexamethyl-eicosahydro-cyclopenta[a]chrysen-9-yl ester; C08630; AIDS-076591; Lup-20(29)-en-3-ol, acetate, (3beta)-; LMPR01060014; AIDS076591; Lup-20(29)-en-3beta-ol, acetate (8CI); NSC 281806; 1617-68-1; EINECS 216-575-8 | C32H52O2 | 468.75 | CC(=C)C1CCC2(C1C3CCC4C5(CCC(C(C5CCC4(C3(CC2)C)C)(C)C)OC(=O)C)C)C |
| TCMBANKIN029463 | kaempferol 3-o-{β-d-glucopyranosyl-(1→2)-[α-l-rhamonopyranosyl-(1→6)]-β-d-galactopyra-noside} | C33H40O20 | |||
| TCMBANKIN031328 | thevetin a | C42H64O19 | 872.9 g/mol | CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CCC5C6=CC(=O)OC6)O)C)C=O)O)OC)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)O)O | |
| TCMBANKIN034150 | perusitin | C30H44O10 | 0 | CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CCC5C6=CC(=O)OC6)O)C)C(=O)O)O)OC)O | |
| TCMBANKIN035233 | cerberin | Pveneniferin; 25633-33-4; CHEBI:75049; 3beta-O-(L-2'-O-acetylthevetosyl)-14beta-hydroxy-5beta-card-20(22)-enolide; C19984; 25633-34-5; 1401-88-3; KW5A155S64; Neriifolin-monoacetat; UNII-KW5A155S64; (3beta,5beta)-3-[(2-O-acetyl-6-deoxy-3-O-methyl-alpha-L-glucopyranosyl)oxy]-14-hydroxycard-20(22)-enolide; 2'-acetylneriifolin; CHEMBL554969; Cerberin; SCHEMBL868106 | C32H48O9 | 576.7 g/mol | CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CCC5C6=CC(=O)OC6)O)C)C)OC(=O)C)OC)O |
| TCMBANKIN038232 | panasenoside | LMPK12111666; Panasenoside | C27H30O16 | 610.52 | C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)OC5C(C(C(C(O5)CO)O)O)O)O |
| TCMBANKIN039013 | quercetin-3-o-[β-d-glucopyranosyl-(1→2)-β-d-glucopyranoside] | C27H30O17 | C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)OC5C(C(C(C(O5)CO)O)O)O)O)O)O | ||
| TCMBANKIN039024 | Peruvianoside I | 494.4 g/mol | |||
| TCMBANKIN041480 | peruvianoside iii | C33H40O21 | 772.7 g/mol | CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=CC(=C4C3=O)O)O)C5=CC(=C(C=C5)O)O)OC6C(C(C(C(O6)CO)O)O)O)O)O)O)O)O | |
| TCMBANKIN042172 | Spetasin | s-petasin | 334.5 g/mol | ||
| TCMBANKIN043108 | Theveside | 390.34 g/mol | |||
| TCMBANKIN043712 | Thevefolin | C30H46O8 | 534.7 g/mol | C1([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])(C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@]([H])(C2=C([H])C(=O)OC2([H])[H])C([H])([H])C3([H])[H])[C@]34O[H])[C@@]4([H])C([H])([H])C5([H])[H]) [C@@]5([H])C([H])([H])[C@@]1([H])O[C@@]([H])(O[C@@]6([H])C([H])([H])[H])[C@@]([H])(O[H])[C@]([H])(OC([H])([H])[H])[C@@]6([H])O[H] | |
| TCMBANKIN044839 | 17β-neriifolin | 17 beta-neriifolin | C30H46O8 | 0 | |
| TCMBANKIN044863 | Peruvianoside II | 494.4 g/mol | |||
| TCMBANKIN058132 | quercetin-3-o-[β-d-glucopyranosyl-(1→2)-β-d-galactopyranoside] | 27459-71-8; Quercetin-3-O-sophoroside; C12667; Quercetin 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside; 3-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromen-4-one; Quercetin 3-beta-D-sophoroside; 3-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-methylol-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromone; Quercetin 3-O-sophoroside; 3-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one; Baimaside; 18609-17-1; 3-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-oxan-2-yl]oxy-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromen-4-one; 4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-((2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-5,7-dihydroxy-; 3-[[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-2-tetrahydropyranyl]oxy]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-chromenone; quercetin-３-Ｏ-β-Ｄ-sophoroside; quercetin-3-sophoroside; QUOSP | 626.52 | C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)OC5C(C(C(C(O5)CO)O)O)O)O)O | |
| TCMBANKIN058216 | Sophoraflavonoloside | 4H-1-Benzopyran-4-one, 3-((2-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-; 3-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-methylol-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-5,7-dihydroxy-2-(4-hydroxyphenyl)chromone; Kaempferol 3-O-beta-D-glucosyl-(1->2)-beta-D-glucoside; sophoraflavonoloside; Kaempferol-3-O-sophoroside; 3-[[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-2-tetrahydropyranyl]oxy]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-chromenone; 3-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-2-yl]oxy-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one; Kaempferol-3-sophoroside; Kaempferol 3-O-beta-D-sophoroside; C12634; 3-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-oxan-2-yl]oxy-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one; Kaempferol 3-O-sophoroside; K3S; Flavone, 3,4',5,7-tetrahydroxy-, 3-(2-O-beta-D-glucopyranosyl-beta-glucopyranoside); 30373-88-7; 3-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one; 19895-95-5; 4H-1-Benzopyran-4-one, 3-((2-O-beta-D-glucopyranosyl-beta-diglucopyranosyl)oxy)-5,7-dihydroxy-2-(4-hydroxyphenyl)-;kaempferol-3-sophoroside | C27H30O16 | 610.52 | C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)OC5C(C(C(C(O5)CO)O)O)O)O |
| TCMBANKIN058550 | theveside | C16H22O11 | 390.34 g/mol | C1C=C(C2C1(C(=COC2OC3C(C(C(C(O3)CO)O)O)O)C(=O)O)O)CO | |
| TCMBANKIN060252 | thevebioside | C36H56O13 | CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CCC5C6=CC(=O)OC6)O)C)C)OC7C(C(C(C(O7)CO)O)O)O)OC)O | ||
| TCMBANKIN060253 | cerberoside | C42H66O18 | 859 g/mol | CC1C(C(C(C(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CCC5C6=CC(=O)OC6)O)C)C)OC7C(C(C(C(O7)COC8C(C(C(C(O8)CO)O)O)O)O)O)O)OC)O | |
| TCMBANKIN060973 | malic acid | C18H32O2 | 280.4 g/mol | CCCCCCCCC1=C(C1)CCCCCCC(=O)O | |
| TCMBANKIN061582 | quercetin-3-o-[(6-o-feruloyl)-β-d-glucopyra-nosyl-(1→2)-β-d-galactopyranoside] | COC1=C(C=CC(=C1)C=CC(=O)OCC2C(C(C(C(O2)OC3C(C(C(OC3OC4=C(OC5=CC(=CC(=C5C4=O)O)O)C6=CC(=C(C=C6)O)O)CO)O)O)O)O)O)O |
植物对应的疾病
| 疾病ID | 病名 | 疾病类型 | MeSH | 参考文献 |
|---|
植物对应的靶点
| 靶点ID | 基因名 | 基因别名 | 描述 | 染色体位置 | Map_Location | 基因类型 |
|---|
滇ICP备16009434号-1 |
Dai SX Lab